A novel finding in this study is that treatment with α-lipoic acid in the Akt-dependent phosphorylation site on mTOR is a strong steatohepatitis protector, leading to enhanced glucose and insulin tolerance and finally hypoglycemia [41,42,43], which was also noticed in our previously published data [18]. This evidence concerns the gene AKT1 and Hypoglycemia.